Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04892017 |
| Title | A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Deciphera Pharmaceuticals LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Washington University Siteman Cancer Center | St Louis | Missouri | 63108 | United States | Details | |
| Rutgers Cancer Institute | New Brunswick | New Jersey | 08901 | United States | Details | |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | United States | Details | |
| Oregon Health and Science University | Portland | Oregon | 97239 | United States | Details | |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| NEXT Oncology | Austin | Texas | 78758 | United States | Details | |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| University of Wisconsin Clinical Science Center | Madison | Wisconsin | 53792 | United States | Details |